Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $9.72 USD
Change Today -0.43 / -4.24%
Volume 994.8K
TROV On Other Exchanges
As of 4:30 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Antonius P. Schuh Ph.D.

Chief Executive Officer and Director, TrovaGene, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 2 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Antonius P. Schuh, Ph.D., has been the Chief Executive Officer of TrovaGene, Inc., since October 2011. Dr. Schuh serves as the Chief Executive Officer of Quikbyte Software, Inc. He served as the Chairman and Chief Executive Officer of Sorrento Therapeutics, Inc. from September 2009 to April 1, 2011 and served as its President until April 1, 2011. He co-founded Sorrento Therapeutics, Inc. He served as the Chief Executive Officer of BioTheranostics, Inc. since March ...

Read Full Background

Corporate Headquarters*

11055 Flintkote Avenue
San Diego, California 92121

United States

Phone: 858-952-7570
Fax: --

Board Members Memberships*

Former Chief Executive Officer and Director
Independent Director
Former Chief Executive Officer, President and Director
Former Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Former Chairman, Chief Executive Officer and President
Chief Executive Officer and Director


Rheinische Friedrich-Wilhelms-Universität Bonn
Bachelor's Degree
Rheinische Friedrich-Wilhelms-Universität Bonn

Other Affiliations*

Annual Compensation*

Total Annual Compensation$539,000

Stock Options*

Exercisable Options537,499
Unexercisable Options520,834
Total Number of Options1,058,333

Total Compensation*

Total Annual Cash Compensation$539,000
Total Short Term Compensation$539,000
Total Calculated Compensation$938,999
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TROV:US $9.72 USD -0.43


David P. King Chairman and Chief Executive Officer
Laboratory Corp. of America Holdings
Gajus V. Worthington Co-Founder, Chief Executive Officer, President and Director
Fluidigm Corporation
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TROVAGENE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at